首页> 外文OA文献 >PMH75 PREDICTORS AND COSTS OF MDD TREATMENT WITH DULOXETINE COMPARED WITH VENLAFAXINE EXTENDED RELEASE

【2h】

PMH75 PREDICTORS AND COSTS OF MDD TREATMENT WITH DULOXETINE COMPARED WITH VENLAFAXINE EXTENDED RELEASE

机译：度洛西汀与文拉法辛延缓释出的PMH75预测值和MDD治疗的费用

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

著录项
引文网络
相似文献
相关主题

著录项

作者
Swindle R; Ye W; Robinson RL; Zhao Y;
展开▼
作者单位

展开▼
年度 2009
总页数
原文格式 PDF
正文语种
中图分类

相似文献

外文文献
中文文献
专利

1. Cost-effectiveness evaluation in Sweden of escitalopram compared with venlafaxine extended-release as first-line treatment in major depressive disorder [J] . Nordstr?mG., DanchenkoN., DespiegelN., Value in health: the journal of the International Society for Pharmacoeconomics and Outcomes Research . 2012,第2期

机译：瑞典艾司西酞普兰与文拉法辛缓释相比作为重度抑郁症的一线治疗的成本-效果评估
2. Cost effectiveness of duloxetine compared with venlafaxine-XR in the treatment of major depressive disorder. [J] . van Baardewijk M, Vis PM, Einarson TR Current medical research and opinion . 2005,第8期

机译：与万拉法辛-XR相比，度洛西汀在治疗重度抑郁症中的成本效益。
3. A randomized, double-blind study comparing the efficacy and safety of trazodone once-a-day and venlafaxine extended-release for the treatment of patients with major depressive disorder [J] . Andrea Fagiolini, Umberto Albert, Laura Ferrando, International clinical psychopharmacology . 2020,第3期

机译：一项随机的双盲研究，比较曲唑酮一次性和venlafaxine的疗效和延长释放治疗重大抑郁症患者的疗效和安全性
4. Using pre-treatment EEG data to predict response to SSRI treatment for MDD [C] . Khodayari-Rostamabad Ahmad, Reilly James P., Hasey Gary, 32nd Annual International Conference of the IEEE Engineering in Medicine and Biology Society . 2010

机译：使用治疗前脑电数据预测对MDD的SSRI治疗的反应
5. The use of the transition cost accounting system to compare costs of treatment between Canada and the United States: Methodological issues based on the case of acute myocardial infarction. [D] . Azoulay, Arik. 2001

机译：使用过渡成本核算系统比较加拿大和美国之间的治疗成本：基于急性心肌梗塞病例的方法学问题。
6. A randomized double-blind study comparing the efficacy and safety of trazodone once-a-day and venlafaxine extended-release for the treatment of patients with major depressive disorder [O] . Andrea Fagiolini, Umberto Albert, Laura Ferrando, -1

机译：一项随机双盲研究比较了曲唑酮每天一次和文拉法辛缓释剂治疗重度抑郁症的疗效和安全性
7. Cost-Effectiveness Evaluation in Sweden of Escitalopram Compared with Venlafaxine Extended-Release as First-Line Treatment in Major Depressive Disorder [O] . Nordström Göran, Danchenko Natalya, Despiegel Nicolas, 2012

机译：瑞典依西酞普兰与文拉法辛延缓释放作为一线治疗严重抑郁症的一线治疗的成本效果评价

PMH75 PREDICTORS AND COSTS OF MDD TREATMENT WITH DULOXETINE COMPARED WITH VENLAFAXINE EXTENDED RELEASE

著录项

引文网络

相似文献

相关主题

期刊订阅